Q1 2020 Holdings
Filed 2020-05-14 | 16 holdings | $30.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcutis Biothereapeutics(ARQT) | Common Stock | 03969K108 | $25.2M | 844,680 | 81.6% |
| Beam Therapeutics(BEAM) | Common Stock | 07373V105 | $5.5M | 302,821 | 17.7% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $52.8K | 5,323,455 | 0.2% |
| Morphic Holding | Common Stock | 61775R105 | $43.6K | 2,969,582 | 0.1% |
| Gossamer Bio(GOSS) | Common Stock | 38341P102 | $43.4K | 4,275,726 | 0.1% |
| Translate Bio | Common Stock | 89374L104 | $24.3K | 2,437,603 | 0.1% |
| Immunic(IMUX) | Common Stock | 4525EP101 | $8.3K | 1,371,494 | 0.0% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $8.2K | 2,600,410 | 0.0% |
| Essa Pharma(EPIEUR) | Common Stock | 29668H708 | $6.8K | 1,689,848 | 0.0% |
| Cidara Therapeutics | Common Stock | 171757107 | $5.0K | 2,008,150 | 0.0% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $4.5K | 130,646 | 0.0% |
| Trevi Therapeutics(TRVI) | Common Stock | 89532M101 | $4.2K | 1,263,408 | 0.0% |
| Prevail Therapeutics | Common Stock | 74140Y101 | $3.3K | 272,807 | 0.0% |
| Jounce Therapeutics(JNCEEUR) | Common Stock | 481116101 | $2.5K | 529,965 | 0.0% |
| ObsEva | Common Stock | H5861P103 | $2.4K | 999,364 | 0.0% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $1.7K | 750,741 | 0.0% |